Global Active Medical Implantable Devices Market, By Product (Cardiac Resynchronization Therapy Devices (CRT-D), Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Eye Implants, Neurostimulators, Active Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop recorders, Brachytheraphy, Implantable Glucose Monitors, Dropped Foot Implants, Shoulder Implants, Implantable Infusion Pumps, and Implantable Accessories), Surgery Type (Traditional Surgical Methods and Minimally Invasive Surgery), Procedure (Neurovascular, Cardiovascular, Hearing, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Clinics) – Industry Trends and Forecast to 2031.
Active Medical Implantable Devices Market Analysis and Size
The active medical implantable devices market encompasses traditional surgical methods and minimally invasive surgery. Instances of traditional methods include open surgeries for joint replacements. In contrast, minimally invasive techniques involve smaller incisions, such as laparoscopic procedures for gallbladder removal. Both approaches utilize active implantable devices such as pacemakers and cochlear implants, catering to diverse medical needs with varying levels of invasiveness.
Data Bridge Market Research analyses that the global active medical implantable devices market, which was USD 21.11 billion in 2023, is expected to reach USD 41.14 billion by 2031, at a CAGR of 8.7% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Active Medical Implantable Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Cardiac Resynchronization Therapy Devices (CRT-D), Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Eye Implants, Neurostimulators, Active Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop recorders, Brachytheraphy, Implantable Glucose Monitors, Dropped Foot Implants, Shoulder Implants, Implantable Infusion Pumps, and Implantable Accessories), Surgery Type (Traditional Surgical Methods and Minimally Invasive Surgery), Procedure (Neurovascular, Cardiovascular, Hearing, and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Clinics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
NeuroPace, Inc. (U.S.), Axonics, Inc. (U.S.), NEVRO CORP (U.S.), BIOTRONIK (Germany), ABIOMED (U.S.), Boston Scientific Corporation (U.S.), Medtronic (Ireland), Abbott (U.S.), Eckert & Ziegler (Germany), Sonova Holding AG (Switzerland), Demant A/S (Denmark), Cochlear Ltd (Australia), Microson S.A.U. (Spain), Oticon Medical A/S (Denmark), Nano Retina (Israel), MED-EL Medical Electronics (Austria), Masimo (U.S.), Hologic, Inc. (U.S.), Varian Medical Systems, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Active medical implantable devices are medical devices designed to be implanted into the body for therapeutic purposes. They are powered by a source such as a battery or external energy and can perform functions such as monitoring, regulating bodily functions, delivering medication, or providing support to tissues or organs.
Global Active Medical Implantable Devices Market Dynamics
Drivers
- Rise in Chronic Diseases Necessitates Implant Solutions
The rise in chronic diseases necessitates implant solutions in the Active medical implantable devices market. Conditions such as cardiovascular diseases, diabetes, and neurological disorders require long-term management, often through implantable devices such as pacemakers, insulin pumps, and neurostimulators. As these diseases become more prevalent globally, the demand for implantable medical devices rises, driving market growth as manufacturers develop innovative solutions to address the growing healthcare needs of patients.
- Collaboration Between Industry Players Fosters Innovation
Through partnerships and alliances, companies leverage complementary expertise, resources, and networks to overcome technological challenges and accelerate product development. This collaborative approach cultivates a fertile environment for creativity and breakthroughs, leading to the creation of cutting-edge implantable solutions that address unmet medical needs. Ultimately, this synergy-driven innovation propels market growth and enhances patient outcomes.
Opportunities
- Aging Population Driving Demand for Medical Implants
The aging population drives the demand for medical implants, as age-related health conditions often necessitate surgical interventions. With an increasing number of elderly individuals requiring joint replacements, pacemakers, and other implants, the market for active medical implantable devices is poised for growth. This demographic shift presents an opportunity for manufacturers to cater to the healthcare needs of aging populations, driving innovation and expansion in the implantable device market.
- Expansion of Healthcare Infrastructure in Emerging Markets
The expansion of healthcare infrastructure in emerging markets opens avenues for the active medical implantable devices market. As these regions enhance their healthcare facilities, there is an increased accessibility to advanced medical procedures, including implant surgeries. This presents an opportunity for device manufacturers to penetrate new markets, cater to growing patient populations, and establish partnerships with healthcare providers, ultimately driving growth and improving healthcare outcomes in these regions.
Restraints/Challenges
- Shortage of Skilled Healthcare Professionals for Surgeries
The shortage of skilled healthcare professionals for implant surgeries is a significant restraint in the active medical implantable devices market. This limitation can lead to delays in procedures, reduced access to implantation services, and compromised patient care. Moreover, inadequate training and expertise may increase the risk of surgical errors and post-operative complications, negatively impacting patient outcomes and eroding confidence in implantable devices, ultimately hindering market growth and adoption.
- Limited Reimbursement Options for Implant Procedures
Limited reimbursement options for implant procedures pose a significant challenge in the active medical implantable devices market. This limitation can deter patients from undergoing implant surgeries due to high out-of-pocket costs, reducing demand for implantable devices. Additionally, healthcare providers may be reluctant to recommend these procedures, leading to decreased utilization of implantable devices and potential revenue loss for manufacturers, thereby stifling market growth and innovation.
This global active medical implantable devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global active medical implantable devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In August 2022, Medtronic plc launched an investigational extravascular implantable cardioverter defibrillator (EV ICD) system, achieving a defibrillation success rate of 98.7% in a global clinical trial. With the lead positioned under the breastbone, outside the heart and veins, this innovation marks a milestone in enhancing safety and efficacy in the active medical implantable devices market
- In February 2022, Abbott initiated patient implants for its dual-chamber leadless pacemaker system, marking a technological breakthrough in leadless pacing. This milestone, part of the AVEIR DR i2i pivotal clinical study, represents the first occurrence globally within the trial, highlighting Abbott's advancements in active medical implantable devices and shaping future pacing technologies
- In January 2021, Boston Scientific obtained FDA approval for its Vercise Deep Brain Stimulation System, comprising an implantable pulse generator for symptom relief. This approval marks an opportunity for the company to broaden its presence in the active medical implantable devices market, offering advanced solutions for neurological disorders and expanding its business prospects
- In December 2020, Health Canada approved Abbott's FreeStyle Libre 2, offering continuous glucose monitoring with customizable alarms for adults and children with diabetes. This expansion into the active medical implantable devices market allows Abbott to diversify its offerings, catering to diabetic patients' needs and fostering growth opportunities in the future
Global Active Medical Implantable Devices Market Scope
The global active medical implantable devices market is segmented on the basis of product, surgery type, procedure, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Cardiac Resynchronization Therapy Devices (CRT-D)
- Implantable Cardioverter Defibrillators
- Transvenous Implantable Cardioverter Defibrillators
- Subcutaneous Implantable Cardioverter Defibrillators
- Implantable Cardiac Pacemakers
- Eye Implant
- Neurostimulators
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Gastric Electrical Stimulators
- Active Implantable Hearing Devices
- Ventricular Assist Devices
- Implantable Heart Monitors/Insertable Loop Recorders
- Brachytheraphy
- Implantable Glucose Monitors
- Dropped Foot Implants
- Shoulder Implants
- Implantable Infusion Pumps
- Implantable Accessories
Surgery Type
- Traditional Surgical Methods
- Minimally Invasive Surgery
Procedure
- Neurovascular
- Cardiovascular
- Hearing
- Others
End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Clinics
Global Active Medical Implantable Devices Market Regional Analysis/Insights
The global active medical implantable devices market is analysed and market size insights and trends are provided by product, surgery type, procedure, and end user as referenced above.
The countries covered in the global active medical implantable devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Asia-Pacific region anticipates the highest growth rate, driven by increased healthcare investments. China's dominance is fuelled by its rapid adoption and advancements in active medical implantable devices. With escalating product usage and development, China plays a pivotal role in shaping the region's market landscape and driving innovation in healthcare technologies.
In Europe, Germany is expected for significant growth due to increased R&D activities in the active medical implantable devices market. This surge underscores Germany's position as a leader in innovation, driving advancements in medical technologies and shaping the region's market trajectory for the forecast period of 2024 to 2031.
In the Middle East and Africa, South Africa anticipates substantial growth in the active medical implantable devices market due to increased demand for treatment. This growth reflects the region's evolving healthcare landscape and highlights South Africa's pivotal role in meeting the healthcare needs of its population during the forecast period of 2024 to 2031.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The global active medical implantable devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global active medical implantable devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global active medical implantable devices market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Active Medical Implantable Devices Market Share Analysis
The global active medical implantable devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global active medical implantable devices market.
Some of the major players operating in the global active medical implantable devices market are:
- NeuroPace, Inc. (U.S.)
- Axonics, Inc. (U.S.)
- NEVRO CORP (U.S.)
- BIOTRONIK (Germany)
- ABIOMED (U.S.)
- Boston Scientific Corporation (U.S.)
- Medtronic (Ireland)
- Abbott (U.S.)
- Eckert & Ziegler (Germany)
- Sonova Holding AG (Switzerland)
- Demant A/S (Denmark)
- Cochlear Ltd (Australia)
- Microson S.A.U. (Spain)
- Oticon Medical A/S (Denmark)
- Nano Retina (Israel)
- MED-EL Medical Electronics (Austria)
- Masimo (U.S.)
- Hologic, Inc. (U.S.)
- Varian Medical Systems, Inc. (U.S.)
SKU-